A detailed history of Pfs Investments Inc. transactions in Abb Vie Inc. stock. As of the latest transaction made, Pfs Investments Inc. holds 369,535 shares of ABBV stock, worth $71.3 Million. This represents 0.81% of its overall portfolio holdings.

Number of Shares
369,535
Previous 353,164 4.64%
Holding current value
$71.3 Million
Previous $57.1 Million 12.74%
% of portfolio
0.81%
Previous 0.99%

Shares

18 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Aug 11, 2023

BUY
$132.51 - $164.9 $2.17 Million - $2.7 Million
16,371 Added 4.64%
369,535 $49.8 Million
Q1 2023

May 15, 2023

BUY
$144.61 - $166.54 $7.76 Million - $8.93 Million
53,633 Added 17.91%
353,164 $57.1 Million
Q4 2022

Feb 13, 2023

SELL
$138.31 - $165.87 $248,128 - $297,570
-1,794 Reduced 0.6%
299,531 $48.4 Million
Q3 2022

Nov 14, 2022

BUY
$134.21 - $153.93 $4.19 Million - $4.8 Million
31,186 Added 11.54%
301,325 $40.4 Million
Q2 2022

Aug 12, 2022

BUY
$137.62 - $174.96 $5.04 Million - $6.41 Million
36,648 Added 15.7%
270,139 $41.4 Million
Q1 2022

May 16, 2022

SELL
$131.98 - $163.75 $6.97 Million - $8.65 Million
-52,813 Reduced 18.45%
233,491 $37.9 Million
Q4 2021

Feb 11, 2022

BUY
$107.43 - $135.93 $2.75 Million - $3.48 Million
25,637 Added 9.84%
286,304 $38.8 Million
Q3 2021

Nov 15, 2021

BUY
$106.4 - $120.78 $2.42 Million - $2.74 Million
22,716 Added 9.55%
260,667 $30.3 Million
Q2 2021

Aug 13, 2021

BUY
$105.21 - $117.21 $5.03 Million - $5.61 Million
47,821 Added 25.15%
237,951 $27.7 Million
Q1 2021

May 17, 2021

BUY
$102.3 - $112.62 $2.78 Million - $3.06 Million
27,185 Added 16.68%
190,130 $20.6 Million
Q4 2020

Feb 16, 2021

BUY
$80.49 - $108.67 $1.67 Million - $2.25 Million
20,705 Added 14.56%
162,945 $17.8 Million
Q3 2020

Nov 13, 2020

BUY
$85.91 - $100.83 $1.59 Million - $1.87 Million
18,540 Added 14.99%
142,240 $12.5 Million
Q2 2020

Aug 14, 2020

BUY
$73.37 - $98.18 $3.24 Million - $4.34 Million
44,194 Added 55.59%
123,700 $12.1 Million
Q1 2020

May 13, 2020

SELL
$64.5 - $97.79 $16,834 - $25,523
-261 Reduced 0.33%
79,506 $6.06 Million
Q4 2019

Feb 12, 2020

BUY
$72.13 - $90.25 $1.37 Million - $1.72 Million
19,057 Added 31.39%
79,767 $7.06 Million
Q3 2019

Nov 05, 2019

BUY
$62.98 - $75.72 $1.19 Million - $1.43 Million
18,890 Added 45.17%
60,710 $4.6 Million
Q2 2019

Jul 10, 2019

BUY
$65.7 - $83.98 $2.09 Million - $2.67 Million
31,794 Added 317.12%
41,820 $3.05 Million
Q1 2019

Apr 05, 2019

BUY
$77.14 - $90.79 $773,405 - $910,260
10,026 New
10,026 $808,000

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $341B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Pfs Investments Inc. Portfolio

Follow Pfs Investments Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Pfs Investments Inc., based on Form 13F filings with the SEC.

News

Stay updated on Pfs Investments Inc. with notifications on news.